Annual Operating Expenses
$69.64 M
+$27.37 M+64.77%
December 31, 2023
Summary
- As of February 8, 2025, ANTX annual total operating expenses is $69.64 million, with the most recent change of +$27.37 million (+64.77%) on December 31, 2023.
- During the last 3 years, ANTX annual operating expenses has risen by +$62.35 million (+856.00%).
- ANTX annual operating expenses is now at all-time high.
Performance
ANTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$11.77 M
-$4.11 M-25.88%
September 30, 2024
Summary
- As of February 8, 2025, ANTX quarterly total operating expenses is $11.77 million, with the most recent change of -$4.11 million (-25.88%) on September 30, 2024.
- Over the past year, ANTX quarterly operating expenses has dropped by -$6.53 million (-35.66%).
- ANTX quarterly operating expenses is now -37.44% below its all-time high of $18.82 million, reached on December 31, 2023.
Performance
ANTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ANTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +64.8% | -35.7% |
| 3 y3 years | +856.0% | -35.7% |
| 5 y5 years | +856.0% | -35.7% |
ANTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +222.8% | -37.4% | +55.0% |
| 5 y | 5-year | at high | +856.0% | -37.4% | +474.2% |
| alltime | all time | at high | +856.0% | -37.4% | +474.2% |
AN2 Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.77 M(-25.9%) |
| Jun 2024 | - | $15.88 M(-13.2%) |
| Mar 2024 | - | $18.30 M(-2.8%) |
| Dec 2023 | $69.64 M(+64.8%) | $18.82 M(+3.5%) |
| Sep 2023 | - | $18.18 M(+9.5%) |
| Jun 2023 | - | $16.60 M(+3.5%) |
| Mar 2023 | - | $16.04 M(+28.6%) |
| Dec 2022 | $42.26 M | $12.48 M(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $11.77 M(+13.9%) |
| Jun 2022 | - | $10.33 M(+34.5%) |
| Mar 2022 | - | $7.68 M(+1.2%) |
| Dec 2021 | $21.57 M(+196.2%) | - |
| Dec 2021 | - | $7.59 M(+9.5%) |
| Sep 2021 | - | $6.93 M(+38.7%) |
| Jun 2021 | - | $5.00 M(+143.8%) |
| Mar 2021 | - | $2.05 M |
| Dec 2020 | $7.28 M | - |
FAQ
- What is AN2 Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for AN2 Therapeutics?
- What is AN2 Therapeutics annual operating expenses year-on-year change?
- What is AN2 Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly operating expenses year-on-year change?
What is AN2 Therapeutics annual total operating expenses?
The current annual operating expenses of ANTX is $69.64 M
What is the all time high annual operating expenses for AN2 Therapeutics?
AN2 Therapeutics all-time high annual total operating expenses is $69.64 M
What is AN2 Therapeutics annual operating expenses year-on-year change?
Over the past year, ANTX annual total operating expenses has changed by +$27.37 M (+64.77%)
What is AN2 Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ANTX is $11.77 M
What is the all time high quarterly operating expenses for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly total operating expenses is $18.82 M
What is AN2 Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ANTX quarterly total operating expenses has changed by -$6.53 M (-35.66%)